Phillips Financial Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Phillips Financial Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-42	Closed	-$950	–	261
2024 Q4	$950	Hold	42	–	–	﹤0.01%	258
2024 Q3	$1.03K	Hold	42	–	–	﹤0.01%	272
2024 Q2	$971	Hold	42	–	–	﹤0.01%	266
2024 Q1	$1.01K	Hold	42	–	–	﹤0.01%	260
2023 Q4	$966	Hold	42	–	–	﹤0.01%	251
2023 Q3	$855	Hold	42	–	–	﹤0.01%	238
2023 Q2	$981	Sell	42 -1,565	-97%	-$37.5K	﹤0.01%	236
2023 Q1	$37.4K	Hold	1,607	–	–	﹤0.01%	200
2022 Q4	$40.4K	Hold	1,607	–	–	﹤0.01%	187
2022 Q3	$42K	Buy	+1,607	New	+$49.6K	﹤0.01%	175

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

CCA

Cora Capital Advisors Marlton, New Jersey $302M AUM 16.46% 1-Year Est. Return

Phillips Financial Management's IDNA Position: Q1 2025 in Review

Phillips Financial Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2025, closing a stake of 42 shares — an estimated $950 sold.

Phillips Financial Management first reported a position in IDNA in Q3 2022 and held it in 10 quarters. The position peaked at $42K in Q3 2022. 48 funds tracked by Wall St. Rank hold IDNA as of Q1 2025.

Phillips Financial Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2025 after selling out during the quarter.
Phillips Financial Management sold 42 iShares Genomics Immunology and Healthcare ETF shares in Q1 2025, an estimated $950.
Phillips Financial Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2022 and held it in 10 quarters.
Phillips Financial Management's iShares Genomics Immunology and Healthcare ETF position peaked at $42K in Q3 2022.
48 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2025.

Based on Phillips Financial Management's 13F filing for Q1 2025, filed 30 Apr 2025.